GlassScriptPhysician profile
Scott Brian Reeder
NPI 1457320376
$38,844.79
in general payments reported to CMS, 2019-2025
12 companies · $18K in 2025
The $18K reported for 2025 was more than what 98% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,722 · 2020: $2,500 · 2021: $3,250 · 2022: $7,460 · 2023: $3,619 · 2024: $680 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $12K · Consulting Fee: $8,728 · Honoraria: $800 · Food and Beverage: $793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $11,591.00 |
| Consulting Fee | $8,728.44 |
| Honoraria | $800.00 |
| Food and Beverage | $793.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $24,036.65 | 2019-2025 | |
| Amgen INC. | $5,228.44 | 2025 | |
| Bayer Healthcare LLC | $3,000.00 | 2023 | |
| Guerbet LLC | $2,261.89 | 2022 | |
| Bracco Diagnostics INC. | $1,792.00 | 2019-2022 | |
| Gilead Sciences, INC. | $1,000.00 | 2022-2023 | |
| Canon Healthcare USA, INC. | $800.00 | 2025 | |
| Siemens Medical Solutions USA, INC. | $680.08 | 2024 | Biograph Vision 600 (8 Ring/64 Ct), Biograph Trinion Ep Ct64 |
| E.R. Squibb & Sons, L.L.C. | $45.73 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Reeder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.